Deep Dive: APOC3 Inhibitors: Tryngolza vs Redemplo
Generated August 2026 · Clinical Deep Dive 0 Comments Until June 2026, choosing between the two FDA-approved APOC3 inhibitors was...
Read moreDetailsGenerated August 2026 · Clinical Deep Dive 0 Comments Until June 2026, choosing between the two FDA-approved APOC3 inhibitors was...
Read moreDetailsTOPLINE Cherry angiomas (CAs) were common in individuals with neurofibromatosis type 1 (NF1) compared with control individuals without NF1. Biallelic...
Read moreDetailsResistance training was associated with a substantially lower risk for type 2 diabetes (T2D), particularly when performed consistently over midlife...
Read moreDetailsHere are the North American anime, manga, and light novel releases for September. Week 1: September 1 - 7 Anime...
Read moreDetailsThe Entertainment Tonight special airs on CBS, with new tributes to Dolly Parton and archival interviews If you purchase an...
Read moreDetails